Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
China regulator approves imports of J&J's Tremfya
BEIJING (Reuters) - China has approved imports of Johnson & Johnson’s Tremfya (guselkumab), the National Medical Products Administration said in a notice on Friday.
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
TOKYO and SOUTH SAN FRANCISCO, Calif.
GSK puts faith in AI to make more successful drugs more quickly
GlaxoSmithKline is ramping up its use of artificial intelligence and recruiting 80 AI specialists by the end of 2020 as it turns to cutting-edge computing to develop medicines of the future.
FDA approves first generics of Eliquis
The U.
AstraZeneca, Daiichi notch blockbuster FDA nod for breast cancer med Enhertu
Enhertu will be co-developed and sold by AstraZeneca and Daiichi, except in Japan where Daiichi owns sole rights.
UCB to build €300M biologics plant, add 150 workers
Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.
A better testing method for patients with Parkinson's disease
Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.
Skin-lightening cream could cause nerve damage, CDC report warns
(HealthDay)—A skin-lightening cream from Mexico that contained toxic mercury left a California woman with significant central nervous system damage, doctors report in a case study.
Bavarian Nordic Announces the Sale of Priority Review Voucher
COPENHAGEN, Denmark, December 17, 2019 – Bavarian Nordic A/S (OMX.
Correvio's heart drug fails to get FDA approval
(Reuters) - The U.
Allergan signs $750 million settlement with purchasers of Alzheimer's drug Namenda
NEW YORK (Reuters) - Purchasers of Allergan Plc’s Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker conspired to keep generic version...
Tweaking DNA fragments before inserting yields highest efficiency rates: study
CHICAGO, Dec.
372
373
374
375
376
377
378
379
380
